The 18-year-old Russian tennis star had opened the tournament with a dominating win.
Akebia Therapeutics (NASDAQ:AKBA) executives outlined the company’s near- and mid-term priorities at the Leerink Partners Global Healthcare Conference, emphasizing the commercialization of its anemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results